MannKind Corp. (MNKD)
3.50
0.00 (0.00%)
USD |
NASDAQ |
Oct 30, 16:00
3.51
+0.01
(+0.29%)
Pre-Market: 20:00
MannKind 30-Day Average Daily Volume : 4.638M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 4.638M |
| October 29, 2026 | 4.755M |
| October 28, 2026 | 4.770M |
| October 27, 2026 | 4.742M |
| October 26, 2026 | 4.781M |
| October 23, 2026 | 4.820M |
| October 22, 2026 | 4.799M |
| October 21, 2026 | 4.797M |
| October 20, 2026 | 4.877M |
| October 19, 2026 | 4.969M |
| October 16, 2026 | 4.981M |
| October 15, 2026 | 4.971M |
| October 14, 2026 | 4.933M |
| October 13, 2026 | 4.743M |
| October 12, 2026 | 4.690M |
| October 09, 2026 | 4.624M |
| October 08, 2026 | 4.541M |
| October 07, 2026 | 4.449M |
| October 06, 2026 | 4.355M |
| October 05, 2026 | 4.346M |
| October 02, 2026 | 4.357M |
| October 01, 2026 | 4.317M |
| September 30, 2026 | 4.159M |
| September 29, 2026 | 3.812M |
| September 28, 2026 | 3.843M |
| Date | Value |
|---|---|
| September 25, 2026 | 3.869M |
| September 24, 2026 | 3.748M |
| September 23, 2026 | 3.752M |
| September 22, 2026 | 3.806M |
| September 21, 2026 | 3.401M |
| September 18, 2026 | 3.418M |
| September 17, 2026 | 3.544M |
| September 16, 2026 | 3.681M |
| September 15, 2026 | 3.777M |
| September 14, 2026 | 3.830M |
| September 11, 2026 | 3.906M |
| September 10, 2026 | 3.962M |
| September 09, 2026 | 3.974M |
| September 08, 2026 | 3.923M |
| September 04, 2026 | 3.936M |
| September 03, 2026 | 4.157M |
| September 02, 2026 | 4.178M |
| September 01, 2026 | 4.276M |
| August 31, 2026 | 4.348M |
| August 28, 2026 | 4.356M |
| August 27, 2026 | 4.406M |
| August 26, 2026 | 4.447M |
| August 25, 2026 | 4.576M |
| August 24, 2026 | 4.624M |
| August 21, 2026 | 4.665M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| United Therapeutics Corp. | 809792.5 |
| ACADIA Pharmaceuticals, Inc. | 2.037M |
| Gilead Sciences, Inc. | 5.928M |
| Vertex Pharmaceuticals, Inc. | 1.263M |
| Ocugen, Inc. | 6.823M |